Curtis Cooper, MD, FRCPC, M.Sc.

Co-infections and Related Conditions Core Co-Leader
Member, Steering Committee

Dr. Cooper is the director of the Ottawa Hospital and Regional Hepatitis Program, a scientist in the Ottawa Hospital Research Institute’s Clinical Epidemiology Program, and an associate professor in the Department of Medicine at the University of Ottawa. Dr. Cooper is the past president of the Canadian Association of HIV Research.

He received his Bachelor of Science degree in biology from the University of Regina, and his medical degree at the University of Saskatchewan before going on to specializations in internal medicine and infectious diseases at the University of Manitoba. Later, he completed an HIV Research Fellowship and a master’s degree in epidemiology at the University of Ottawa.

Dr. Cooper’s research surrounds HIV, viral hepatitis and vaccine development. He is working towards the development of new therapeutic agents and the delivery of treatment that maximizes safety and adherence.

He is involved in many CTN studies, all within the Co-infections and Related Conditions Core, and he was a co-author of the CTN 2016 HIV-HCV Co-infection Guidelines. He is the principal investigator and for CTNPT 019, CTN 289, CTN 237, and CTN 253, and a co-investigator for CTN 286, CTN 222, CTN 260, and CTN 264.